omniture
logo
Search
天辰生物医药(苏州)有限公司
Media Room

Latest News

rss

Food Allergy: LongBio's LP-003 achieves its fourth IND approval

SHANGHAI, Nov. 25, 2024 /PRNewswire/ -- LongBio is proud to announce that the National Medical Prod...

2024-11-25 22:00 1249

LongBio announced the completion of Series B2 financing, led by Qiming Venture Partners

SHANGHAI, Sept. 24, 2024 /PRNewswire/ -- LongBio Pharma (Suzhou) Co., Ltd. ("LongBio" or the "Compa...

2024-09-24 21:00 1730

Pre-clinical result of LP-005, a novel bi-functional complement antibody-fusion protein was unveiled by LongBio at WCN2024

BUENOS AIRES, Argentina, April 15, 2024 /PRNewswire/ -- LongBio Pharma (Suzhou) Co., Ltd. (referred...

2024-04-16 02:00 1243

Longbio Pharma Presented Positive Phase 1 Results for LP-003 at 2024AAD

SAN DIEGO, March 12, 2024 /PRNewswire/ -- Longbio Pharma (Suzhou) Co., Ltd. (referred to as "Longbi...

2024-03-12 20:00 1634

Groundbreaking! Phase II Data of LP-003 Unveiled by Longbio Pharma at AAAAI2024

WASHINGTON, Feb. 25, 2024 /PRNewswire/ -- Longbio Pharma (Suzhou) Co., Ltd. (referred to as "Longbi...

2024-02-26 02:00 1434

Longbio Pharma Presented Positive Topline Phase 1 Results for LP-003 at JSA2023

TOKYO, Oct. 23, 2023 /PRNewswire/ -- Longbio Pharma (Suzhou) Co., Ltd. (abbreviated as "Longbio Pha...

2023-10-23 12:27 1953

Longbio Pharma Presented Positive Topline Phase 1 Results for LP-003 at ERS2023

SOFIA, Bulgaria, June 20, 2023 /PRNewswire/ -- Longbio Pharma (Suzhou) Co., Ltd. (abbreviated as "L...

2023-06-20 21:00 1920